Inflammation & Allergy - Drug Targets (Discontinued)

Kurt S Zaenker
Institute of Immunology and Experimental Oncology
University Witten/Herdecke
Stockumerstraße 10
Witten, 58448
(Germany)

View Full Editorial Board

Inflammation & Allergy - Drug Targets (Discontinued)

Formerly: 'Current Drug Targets - Inflammation & Allergy

Contents

Inflammation & Allergy - Drug Targets (Discontinued), Volume 5 - Number 4

Pollen-Cross Allergenicity Mediated by Panallergens: A Clue to the Pathogenesis of Multiple Sensitizations

Samuele E. Burastero

Role of Regulatory T Cells in Allergy: Implications for Therapeutic Strategy

Eyad Elkord

Chemokines in Allergic Aspergillosis - From Animal Models to Human Lung Diseases

Dominik Hartl, Karen F. Buckland and Cory M. Hogaboam

Complex Effect of Adenovirus Early Region Proteins on Innate Immune System

Yuji Higashimoto, Yuko Yamagata and Hidekazu Itoh

CD4+CD25+ Regulatory T-Cell Therapy for Allergy, Autoimmune Disease and Transplant Rejection

Shuiping Jiang and Robert I. Lechler

Immunotherapeutic Targeting of Allergic Disease

Gabriela Senti, Julia M. Martinez Gomez, Lorna Rettig, Brunello Wuthrich, Thomas M. Kundig and Pal Johansen

Interferon-γ as a Possible Target in Chronic Asthma

Rakesh K. Kumar, Dianne C. Webb, Cristan Herbert and Paul S. Foster

Hyaluronan: The Jekyll and Hyde Molecule

Jerome O. Cantor and Priya P. Nadkarni

Molecular Cloning of Blomia tropicalis Allergens - A Major Source of Dust Mite Allergens in the Tropics and Subtropics

Fong Cheng Yi, Lynette Pei-Chi Shek, Nge Cheong, Kaw Yan Chua and Bee Wah Lee

Editor-in-Chief

Quick Links

Advertisement

Related Journals

Related eBooks

eBooks Catalog